Muscle-Targeted Therapeutics That Can Be Combined with Obesity Drugs to Improve the Quality of Weight Management
Time: 2:40 pm
day: Day One
Details:
- Addressing the concern of muscle loss, as a side effect of GLP-1 medications, through the development of muscle preservation and stimulation approaches
- Exploring the synergistic potential of combining these muscle stimulants with existing obesity therapies to improve weight loss outcomes
- Optimizing the development of safe and effective muscle stimulants by focusing on specific targets and innovative delivery mechanisms
